- Home
- EVO vs DQ Comparison
EVO vs DQ Comparison
Compare EVO & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- DQ
- Stock Information
- Founded
- EVO 1993
- DQ 2006
- Country
- EVO Germany
- DQ China
- Employees
- EVO N/A
- DQ N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- DQ Semiconductors
- Sector
- EVO Health Care
- DQ Technology
- Exchange
- EVO Nasdaq
- DQ Nasdaq
- Market Cap
- EVO 1.5B
- DQ 1.4B
- IPO Year
- EVO 2021
- DQ 2010
- Fundamental
- Price
- EVO $4.30
- DQ $13.10
- Analyst Decision
- EVO Buy
- DQ Hold
- Analyst Count
- EVO 2
- DQ 6
- Target Price
- EVO $5.90
- DQ $20.31
- AVG Volume (30 Days)
- EVO 154.6K
- DQ 857.5K
- Earning Date
- EVO 05-06-2025
- DQ 04-29-2025
- Dividend Yield
- EVO N/A
- DQ N/A
- EPS Growth
- EVO N/A
- DQ N/A
- EPS
- EVO N/A
- DQ N/A
- Revenue
- EVO $851,944,444.00
- DQ $737,683,000.00
- Revenue This Year
- EVO $11.29
- DQ N/A
- Revenue Next Year
- EVO $13.20
- DQ $66.29
- P/E Ratio
- EVO N/A
- DQ N/A
- Revenue Growth
- EVO 1.50
- DQ N/A
- 52 Week Low
- EVO $2.84
- DQ $12.41
- 52 Week High
- EVO $5.68
- DQ $30.85
- Technical
- Relative Strength Index (RSI)
- EVO 61.35
- DQ 38.10
- Support Level
- EVO $3.91
- DQ $12.72
- Resistance Level
- EVO $4.38
- DQ $13.45
- Average True Range (ATR)
- EVO 0.13
- DQ 0.70
- MACD
- EVO 0.01
- DQ 0.14
- Stochastic Oscillator
- EVO 86.89
- DQ 23.87
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.